About ABclonal Biotechnology
ABclonal Biotechnology is a company based in Woburn (United States) founded in 2006. ABclonal Biotechnology has raised $281.25 million across 2 funding rounds from investors including Luxin Venture Capital Group, Sigma Square Capital and Sequoia Capital. ABclonal Biotechnology operates in a competitive market with competitors including Abcam, Stem Cell Technologies, Meridian Bioscience, Teknova and Sangon Biotech, among others.
- Headquarter Woburn, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$281.25 M (USD)
in 2 rounds
-
Latest Funding Round
$188.35 M (USD), Series D
Dec 08, 2021
-
Investors
Luxin Venture Capital Group
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of ABclonal Biotechnology
Unlock access to complete
Funding Insights of ABclonal Biotechnology
ABclonal Biotechnology has successfully raised a total of $281.25M across 2 strategic funding rounds. The most recent funding activity was a Series D round of $188.35 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ABclonal Biotechnology
ABclonal Biotechnology has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Luxin Venture Capital Group, Sigma Square Capital and Sequoia Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Mid-market companies are targeted for investment by Loayal Valley Capital.
|
Locked | Locked | Locked | |
|
Sequoia Capital is engaged in venture capital investments.
|
Locked | Locked | Locked | |
|
LYFE Capital is recognized as a premier healthcare investment platform.
|
Locked | Locked | Locked |
Investor details for ABclonal Biotechnology
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ABclonal Biotechnology
Investment portfolio details for ABclonal Biotechnology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ABclonal Biotechnology
Detailed financials for ABclonal Biotechnology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Abclonal Biotechnology Comparisons
Peer comparison for ABclonal Biotechnology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ABclonal Biotechnology
ABclonal Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, Meridian Bioscience, Teknova and Sangon Biotech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biological reagents and antibodies are developed for life science research.
|
|
| Locked | Locked | Locked |
Developer of cell culture media and ancillary reagents for life science research
|
|
| Locked | Locked | Locked |
Molecular diagnostic device and kits
|
|
| Locked | Locked | Locked |
Molecular biology reagents and kits are supplied for research applications.
|
|
| Locked | Locked | Locked |
Research services, reagents, and kits for biotech applications are provided.
|
|
| Locked | Locked | Locked |
Bioreagents and assay kits are developed, with preclinical services provided.
|
Detailed competitors of ABclonal Biotechnology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Abclonal Biotechnology
Complete news archive for ABclonal Biotechnology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ABclonal Biotechnology
ABclonal Biotechnology was founded in 2006 and raised its 1st funding round 14 years after it was founded.
ABclonal Biotechnology is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
ABclonal Biotechnology is a funded company, having raised a total of $281.25M across 2 funding rounds to date.
ABclonal Biotechnology was founded in 2006 and is based in Woburn, United States, within the biotechnology sector. Protein reagents and kits for cell and molecular biology research are produced, including monoclonal and polyclonal antibodies, recombinant proteins, ELISA kits, and gene clones. Services such as peptide synthesis, custom antibody development, and protein expression in bacterial, insect, yeast, or mammalian systems are offered to support research operations.
ABclonal Biotechnology's top competitors include Abcam, Meridian Bioscience and Stem Cell Technologies.
ABclonal Biotechnology has 9 investors. Key investors include Luxin Venture Capital Group, Sigma Square Capital, Sequoia Capital, CMB International Capital, and Taikang Asset Management.